Cancer

A groundbreaking clinical trial presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting heralds a transformative shift...

Over the past decade, artificial intelligence (AI) has steadily transformed numerous facets of medicine, offering novel tools and methodologies designed...

In recent years, the advent of chimeric antigen receptor (CAR) T cell therapy has revolutionized the landscape of cancer immunotherapy,...

In the evolving landscape of oncology research, the SONIA trial stands out as a compelling example of how academic endeavors...

In the relentless quest to conquer cancer, new and innovative approaches continue to emerge, redefining the boundaries of oncological treatment...

In the rapidly evolving landscape of cancer research, single-cell RNA sequencing (scRNA-seq) has emerged as a transformative technology, reshaping our...

The landscape of cancer treatment is undergoing a transformative evolution, driven by the cutting-edge integration of nanotechnology and immunotherapy. A...

In recent years, the landscape of cancer treatment has witnessed a revolutionary shift, with immunotherapy emerging as one of the...

In recent years, the landscape of non-small-cell lung cancer (NSCLC) treatment has undergone a revolutionary transformation, largely driven by the...

In recent years, the receptor tyrosine kinase HER3 (also known as ErbB3) has emerged from relative obscurity to occupy a...

In the relentless quest to better understand and treat cancer, the concept of surrogate end points has surfaced as a...

In recent years, the intricate relationship between DNA repair mechanisms and cancer development has come into sharper focus, spotlighting a...

In recent years, the landscape of multiple myeloma (MM) diagnosis and treatment has undergone a profound transformation, largely driven by...

The landscape of cancer diagnostics has witnessed transformative advancements, particularly in the realm of human epidermal growth factor receptor 2...

In an era where early cancer detection defines the edge of clinical success, a groundbreaking study published in BMC Cancer...

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology, persistently defying decades of therapeutic innovation and...

The landscape of non-small cell lung cancer (NSCLC) treatment has undergone a radical transformation in recent years, driven by advances...

In a significant advancement for the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a phase II clinical trial spearheaded...

The landscape of anal squamous cell carcinoma (ASCC), a rare yet increasingly prevalent malignancy, is undergoing a profound transformation fueled...

The relentless challenge posed by glioblastoma multiforme (GBM), the most aggressive and lethal primary brain tumor, continues to galvanize oncological...